Blog

We have lost Ed White, advocate, researcher and supporter

We’re extremely sad to share the news that we have lost Ed White, advocate, researcher, supporter and key figure in the psychiatric drug withdrawal movement. Sadly, Ed ended his life on Wednesday 13th October 2021. Despite his own struggle with antidepressant withdrawal, Ed worked tirelessly to support others online and to fight for change for …

Tackling the Problem of Antidepressant Withdrawal

On World Mental Health Day 2021, IIPDW Chairperson, Professor John Read wrote: This World Mental Health Day (October 10), nearly 8 million adults in England (17 percent of the adult population) will be on prescribed antidepressants. Sadly, none of them will receive any specialised help from the National Health Service (NHS) with the withdrawal symptoms that more than half of …

Jim van Os and Peter Groot discuss their latest research on Tapering Strips

Recently for the Mad in America podcast, James Moore was in discussion with Professor Jim van Os and Doctor Peter Groot about their recent research on tapering strips, published in Therapeutic Advances in Psychopharmacology. Jim van Os is Professor of Psychiatric Epidemiology and Public Mental Health at Utrecht University Medical Centre, the Netherlands and Peter …

The Psychiatric Drugging of Children – Town Hall Discussion

Friday 13th August at 5pm BST, 12PM EDT, 9AM PDT Mad in America, the Council for Evidence- based Psychiatry, the International Institute for Psychiatric Drug Withdrawal and A Disorder 4 Everyone are pleased to announce a series of live, online town hall discussions focussing on issues related to psychiatric drug withdrawal. Each town hall will …

The case for establishing a minimal medication alternative for psychosis and schizophrenia

A new article in the journal Psychosis examines whether everyone with a psychotic condition needs long-term antipsychotic treatment and evidence for alternative models of care. The article recommends that healthcare providers should be encouraged to develop a psychosocial treatment package for people with psychosis or schizophrenia that provides a realistic possibility of minimising antipsychotic exposure. …

Stories of Reducing Antipsychotics: withdrawal effects or relapse?

The RADAR Study team are hosting an online webinar on Wednesday 9th June, 2-3:30pm BST, exploring lived experience perspectives on attempting to distinguish withdrawal effects from relapse, when reducing antipsychotics. Although there is increasing awareness of the difficulties in coming off psychiatric drugs, with antidepressants receiving attention in research and services, the effects of coming …

Special issue on Withdrawal from Prescribed Psychotropic Drugs

The Winter 2020 issue of the Journal of Critical Psychology, Counselling and Psychotherapy (JCPCP, 20,4), edited by Peter Lehmann, is a special issue on Withdrawal from Prescribed Psychotropic Drugs. It features articles on Medically unexplained symptoms and Functional neurological disorders Minimum dosage and monitoring of neuroleptics Recovering compensation for psychiatric withdrawal harm through litigation  Internationally known authors …

An Open Letter to NICE in the UK

Professor John Read, Chairperson of the Board of the International Institute for Psychiatric Drug Withdrawal has sent an open letter to Paul Chrisp, Director of the Centre for Guidelines, National Institute for Health and Care Excellence (NICE) in the UK. To: Paul Chrisp –  Director, Centre for Guidelines, National Institute for Health and Care Excellence  …

New paper on stopping antipsychotics is deemed a historic breakthrough

A new paper published in Schizophrenia Bulletin by Mark Horowitz, Sameer Jauhar, Sridhar Natesan, Robin Murray and David Taylor shows how extremely slow tapering off antipsychotics over months or years could reduce the potential negative experiences associated with antipsychotic withdrawal. The paper has been described as a ‘historic breakthrough’ in a recent article in the …